目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. Regional Scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. DNA Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. DNA Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape

Chapter 4. DNA Diagnostics Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. DNA Diagnostics Market: Technology Movement Analysis
4.3. DNA Diagnostics Market by Technology Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. PCR-based Diagnostics
4.5.1. PCR-based Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. NGS DNA Diagnosis
4.6.1. NGS DNA Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. In-Situ Hybridization Diagnostics
4.7.1. In-Situ Hybridization Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Microarrays-based Diagnostics
4.8.1. Microarrays-based Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Other Technologies
4.9.1. In Other Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. DNA Diagnostics Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. DNA Diagnostics Market: Application Movement Analysis
5.3. DNA Diagnostics Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Cancer Genetics Tests
5.5.1. Cancer Genetics Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Infectious Diseases DNA Testing
5.6.1. Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. HBV Diagnostic
5.6.2.1. HBV Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. TB Diagnostic
5.6.3.1. TB Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. CT/NG Diagnostic
5.6.4.1. CT/NG Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.5. HPV Diagnostic
5.6.5.1. HPV Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.6. MRSA Diagnostic
5.6.6.1. MRSA Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.7. Others
5.6.7.1. Others Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Newborn Genetic Screening
5.7.1. Newborn Genetic Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Preimplantation & Reproductive Diagnosis
5.8.1. Preimplantation & Reproductive Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Non-Infectious Diseases DNA Testing
5.9.1. Non-Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.2. Cardiovascular Diseases
5.9.2.1. Cardiovascular Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.3. CNS & PNS Related
5.9.3.1. CNS & PNS Related Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.4. Skeletal, Connective, Ectodermal & Dermal DNA Testing
5.9.4.1. Skeletal, Connective, Ectodermal & Dermal DNA Testing Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.5. Lung, Kidney, Liver & GT Related
5.9.5.1. Lung, Kidney, Liver & GT Related Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.6. Sensory Diseases
5.9.6.1. Sensory Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Prenatal DNA Carrier Screening
5.10.1. Prenatal DNA Carrier Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Pharmacogenomics/Drug Metabolism
5.11.1. Pharmacogenomics/Drug Metabolism Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.12. Hematology & Immunology/Identity Diagnostics & Forensics
5.12.1. Hematology & Immunology/Identity Diagnostics & Forensics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.13. Others
5.13.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. DNA Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional DNA Diagnostics Market movement analysis
6.3. DNA Diagnostics Market: Regional Estimates & Trend Analysis by Technology, Biomaterial & End-use
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. North America
6.5.1. North America DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. U.S.
6.5.2.1. U.S. DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2.2. Key Country Dynamics
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Scenario
6.5.2.5. Competitive Scenario
6.5.3. Canada
6.5.3.1. Canada DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3.2. Key Country Dynamics
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Scenario
6.5.3.5. Competitive Scenario
6.5.4. Europe
6.5.5. Europe DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. UK
6.5.6.1. UK DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6.2. Key Country Dynamics
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Scenario
6.5.6.5. Competitive Scenario
6.5.7. Germany
6.5.7.1. Germany DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7.2. Key Country Dynamics
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Scenario
6.5.7.5. Competitive Scenario
6.5.8. France
6.5.8.1. France DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8.2. Key Country Dynamics
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Scenario
6.5.8.5. Competitive Scenario
6.5.9. Italy
6.5.9.1. Italy DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9.2. Key Country Dynamics
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Scenario
6.5.9.5. Competitive Scenario
6.5.10. Spain
6.5.10.1. Spain DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.10.2. Key Country Dynamics
6.5.10.3. Regulatory Framework
6.5.10.4. Reimbursement Scenario
6.5.10.5. Competitive Scenario
6.5.11. Denmark
6.5.11.1. Denmark DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.11.2. Key Country Dynamics
6.5.11.3. Regulatory Framework
6.5.11.4. Reimbursement Scenario
6.5.11.5. Competitive Scenario
6.5.12. Norway
6.5.12.1. Norway DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.12.2. Key Country Dynamics
6.5.12.3. Regulatory Framework
6.5.12.4. Reimbursement Scenario
6.5.12.5. Competitive Scenario
6.5.13. Sweden
6.5.13.1. Sweden DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.13.2. Key Country Dynamics
6.5.13.3. Regulatory Framework
6.5.13.4. Reimbursement Scenario
6.5.13.5. Competitive Scenario
6.6. Asia Pacific
6.6.1. Asia Pacific DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Japan DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2.2. Key Country Dynamics
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Scenario
6.6.2.5. Competitive Scenario
6.6.3. China
6.6.3.1. China DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3.2. Key Country Dynamics
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Scenario
6.6.3.5. Competitive Scenario
6.6.4. India
6.6.4.1. India DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4.2. Key Country Dynamics
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Scenario
6.6.4.5. Competitive Scenario
6.6.5. South Korea
6.6.5.1. South Korea DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5.2. Key Country Dynamics
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Scenario
6.6.5.5. Competitive Scenario
6.6.6. Australia
6.6.6.1. Australia DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6.2. Key Country Dynamics
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Scenario
6.6.6.5. Competitive Scenario
6.6.7. Thailand
6.6.7.1. Thailand DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7.2. Key Country Dynamics
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Scenario
6.6.7.5. Competitive Scenario
6.7. Latin America
6.7.1. Latin America DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2.1. Brazil DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2.2. Key Country Dynamics
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Scenario
6.7.2.5. Competitive Scenario
6.7.3. Argentina
6.7.3.1. Argentina DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3.2. Key Country Dynamics
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Scenario
6.7.3.5. Competitive Scenario
6.7.4. Mexico
6.7.4.1. Mexico DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.4.2. Key Country Dynamics
6.7.4.3. Regulatory Framework
6.7.4.4. Reimbursement Scenario
6.7.4.5. Competitive Scenario
6.8. Middle East & Africa
6.8.1. Middle East & Africa DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. South Africa DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.2.2. Key Country Dynamics
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Scenario
6.8.2.5. Competitive Scenario
6.8.3. Saudi Arabia
6.8.3.1. Saudi Arabia DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3.2. Key Country Dynamics
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Scenario
6.8.3.5. Competitive Scenario
6.8.4. UAE
6.8.4.1. UAE DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4.2. Key Country Dynamics
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Scenario
6.8.4.5. Competitive Scenario
6.8.5. Kuwait
6.8.5.1. Kuwait DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.5.2. Key Country Dynamics
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Scenario
6.8.5.5. Competitive Scenario

Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Company Categorization
7.3. Strategy Mapping
7.3.1. NEW PRODUCT LAUNCH
7.3.2. PARTNERSHIPS
7.3.3. ACQUISITION
7.3.4. COLLABORATION
7.4. Key Company Market Share Analysis, 2024
7.5. Key Company Profiles
7.5.1. Abbott
7.5.1.1. Company overview
7.5.1.2. Financial performance
7.5.1.3. Technology benchmarking
7.5.1.4. Strategic initiatives
7.5.2. F. Hoffmann-La Roche Ltd.
7.5.2.1. Company overview
7.5.2.2. Financial performance
7.5.2.3. Technology benchmarking
7.5.2.4. Strategic initiatives
7.5.3. QIAGEN
7.5.3.1. Company overview
7.5.3.2. Financial performance
7.5.3.3. Technology benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Bio-Rad Laboratories, Inc.
7.5.4.1. Company overview
7.5.4.2. Financial performance
7.5.4.3. Technology benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Thermo Fisher Scientific, Inc.
7.5.5.1. Company overview
7.5.5.2. Financial performance
7.5.5.3. Technology benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Illumina, Inc.
7.5.6.1. Company overview
7.5.6.2. Financial performance
7.5.6.3. Technology benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Hologic, Inc.
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Technology benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Agilent Technologies Inc.
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Technology benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Siemens Healthineers AG
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Technology benchmarking
7.5.9.4. Strategic initiatives
7.5.10. Danaher Corporation
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Technology benchmarking
7.5.10.4. Strategic initiatives

List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 4. Global DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 5. North America DNA diagnostics market, by region, 2018 - 2030 (USD Million)
Table 6. North America DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 7. North America DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 8. U.S. DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 9. U.S. DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 10. Canada DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 11. Canada DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 12. Mexico DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 13. Mexico DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 14. Europe DNA diagnostics market, by country, 2018 - 2030 (USD Million)
Table 15. Europe DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 16. Europe DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 17. UK DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 18. UK DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 19. Germany DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 20. Germany DNA diagnostics market, by application 2018 - 2030 (USD Million)
Table 21. France DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22. France DNA diagnostics market, by application 2018 - 2030 (USD Million)
Table 23. Italy DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 24. Italy DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 25. Spain DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 26. Spain DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 27. Denmark DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 28. Denmark DNA diagnostics market, by application 2018 - 2030 (USD Million)
Table 29. Norway DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 30. Norway DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 31. Sweden DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 32. Sweden DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 33. Asia Pacific DNA diagnostics market, by country, 2018 - 2030 (USD Million)
Table 34. Asia Pacific DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 35. Asia Pacific DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 36. Japan DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 37. Japan DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 38. China DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 39. China DNA diagnostics market, by application 2018 - 2030 (USD Million)
Table 40. India DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 41. India DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 42. Australia DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 43. Australia DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 44. South Korea DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 45. South Korea DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 46. Thailand DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 47. Thailand DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 48. Latin America DNA diagnostics market, by country, 2018 - 2030 (USD Million)
Table 49. Latin America DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 50. Latin America DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 51. Brazil DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 52. Brazil DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 53. Argentina DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 54. Argentina DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 55. Middle East & Africa DNA diagnostics market, by country, 2018 - 2030 (USD Million)
Table 56. Middle East & Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 58. South Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 59. South Africa DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60. Saudi Arabia DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 62. UAE DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 63. UAE DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 64. Kuwait DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 65. Kuwait DNA diagnostics market, by application, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 DNA diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Technology snapshot
Fig. 10 Application snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market value, 2024 (USD Million)
Fig. 13 Market dynamics
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 DNA diagnostics market: Technology outlook and key takeaways
Fig. 17 DNA diagnostics market: Technology movement analysis
Fig. 18 PCR-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Microarrays-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 In-situ hybridization diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 NGS DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 DNA diagnostics market: Application outlook and key takeaways
Fig. 24 DNA diagnostics market: Application movement analysis
Fig. 25 Cancer genetics tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 HBV diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 TB diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 CT/NG diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 HPV diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 MRSA diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Other infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Preimplantation & reproductive diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Non-infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Cardiovascular diseases diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 CNS & PNS related market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Skeletal, connective, ectodermal & dermal DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Lung, kidney, liver & GT related market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Sensory diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Prenatal DNA carrier screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Pharmacogenomics/drug metabolism market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Hematology & immunology/identity diagnostics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 DNA diagnostics market revenue, by region, 2024 & 2030 (USD Million)
Fig. 46 Regional marketplace: Key takeaways
Fig. 47 Regional marketplace: Key takeaways
Fig. 48 North America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 U.S. DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Canada DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Mexico DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Europe DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 UK DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Germany DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 France DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Spain DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Italy DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Denmark DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Sweden DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Norway DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Rest of Europe DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Asia Pacific DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Japan DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 China DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 China regulatory details
Fig. 79 Key country dynamics
Fig. 80 India DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Australia DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Thailand DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 South Korea DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 South Korean regulations in four hierarchical orders
Fig. 88 Rest of Asia Pacific DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Latin America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Brazil DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Argentina DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Rest of Latin America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 MEA DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 South Africa DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Saudi Arabia DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 UAE DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Kuwait DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Rest of MEA DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key company categorization
Fig. 106 Heat map analysis
Fig. 107 Strategic framework